Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.93 USD | -3.53% |
|
-1.60% | -11.45% |
06-18 | Stifel Initiates Celldex Therapeutics at Buy Rating With $58 Price Target | MT |
06-11 | Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Official Publications